Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma
NCT00459849 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175
Last updated 2008-05-09
Summary
Plaque radiotherapy is a common treatment for uveal melanoma. However, local failure has been reported in up to 20% of patients. We use intraoperative ultrasonography at plaque insertion and removal to evaluate plaque movement as a potential factor in local failure.
Conditions
Interventions
- PROCEDURE
-
Intraoperative ultrasonography
Intraoperative ultrasonography will be used to determine plaque placement.
Sponsors & Collaborators
-
Barnes Retina Institute
lead OTHER
Principal Investigators
-
J W Harbour, MD · Washington University School of Medicine
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-07-31
- Primary Completion
- 2007-07-31
- Completion
- 2007-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis
NCT00404742 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
NCT00436553 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal MTX and ZR Regimen in Newly Diagnosed PVRL
NCT04899453 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis
NCT00404885 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
NCT01942213 ·Status: COMPLETED
-
High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy
NCT01334879 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Of Radiation Retinopathy Trial
NCT00811200 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy
NCT00679445 ·Status: COMPLETED ·Phase: PHASE2
-
Geographic Atrophy and Intravitreal Ranibizumab Injections
NCT02372916 ·Status: UNKNOWN
-
Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.
NCT02321839 ·Status: COMPLETED ·Phase: PHASE4
-
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
NCT00433017 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion
NCT01291121 ·Status: COMPLETED ·Phase: NA
-
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
NCT00749021 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments
NCT00976222 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab
NCT04377295 ·Status: COMPLETED
-
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
NCT00605943 ·Status: COMPLETED
-
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
NCT01314417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Intravitreal Celecoxib for Chronic Uveitis
NCT02131012 ·Status: TERMINATED ·Phase: PHASE1
-
Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
NCT00559715 ·Status: UNKNOWN ·Phase: PHASE3
-
Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
NCT02169648 ·Status: UNKNOWN ·Phase: NA
-
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
NCT00765921 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration
NCT00288561 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
NCT02510794 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration
NCT02398500 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma
NCT05308901 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2